NEXORA PEPTIDES
← Back to library
NEXORA Tirzepatide 60 mg research vial

Incretin receptor agonist

Tirzepatide

Tirzepatide

A dual GIP and GLP-1 receptor agonist investigated and used in regulated pharmaceutical settings.

Research specification

60 mg per vial

Private quote available

For Research Purposes Only

Request a Quote

Product research overview

Evidence for approved pharmaceutical formulations should not be extrapolated to unverified research vials.

Research starting points